Carumonam versus ceftazidime for urinary tract infections.

Carumonam is a new monobactam antibiotic with potent activity against gram-negative aerobes. To study the efficacy and safety of carumonam for treatment of complicated and uncomplicated urinary tract infections, 54 patients were randomized to therapy with either carumonam or ceftazidime. Of 42 patie...

Полное описание

Библиографические подробности

Опубликовано в::	Antimicrob Agents Chemother
Главные авторы:	Edelstein, H, Oster, S, Cassano, K, McCabe, R
Формат:	Artigo
Язык:	Inglês
Опубликовано:	American Society for Microbiology (ASM) 1988
Предметы:	Research Article
Online-ссылка:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC172338/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3056245/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.32.7.1031
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!